What is Esperion Therapeutics's long-term debt?

Esperion Therapeutics (ESPR) reported long-term debt of $152.67M in Q1 2026.

How has Esperion Therapeutics's long-term debt changed year-over-year?

Esperion Therapeutics's long-term debt increased by 7.9% year-over-year, from $141.45M to $152.67M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Esperion Therapeutics ESPR Long-Term Debt

Long-Term Debt at other companies

AmgenAMGN

$51.89B-3.9%

Regeneron PharmaceuticalsREGN

$1.99B+0.1%

Lexicon PharmaceuticalsLXRX

$49.68M-15.3%

Zevra Therapeutics, Inc.ZVRA

$0-100%

Eton Pharmaceuticals, Inc.ETON

$18.94M-36.9%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermDebtNoncurrent.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's long-term debt?: Esperion Therapeutics (ESPR) reported long-term debt of $152.67M in Q1 2026.
How has Esperion Therapeutics's long-term debt changed year-over-year?: Esperion Therapeutics's long-term debt increased by 7.9% year-over-year, from $141.45M to $152.67M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.